Sun Pharma acquires Organon in a definitive all-cash agreement that significantly reshapes the global pharmaceutical landscape. The transaction values Organon at an enterprise value of $11.75 billion. Moreover, shareholders will receive $14.00 per share, offering immediate value realisation.
The deal aligns with Sun Pharmaceutical Industries Limited’s long-term strategy to expand...
Sun Pharma acquires Organon in a definitive all-cash agreement that significantly reshapes the global pharmaceutical landscape. The transaction values...
The Trident Resources option agreement marks a significant step in strengthening the company’s exploration footprint within Saskatchewan’s prolific La...
Kornit Digital acquires PrintFactory to strengthen its platform strategy and accelerate the shift toward digital, on-demand textile manufacturing. The...
Introduction to PonyWorld 2.0 Autonomous Driving
PonyWorld 2.0 autonomous driving marks a significant evolution in the development of self-improving AI...
